DrugPatentWatch Database Preview
LUCENTIS Drug Profile
» See Plans and Pricing
Summary for Tradename: LUCENTIS
| Patents: | 197 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for LUCENTIS |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for LUCENTIS |
Recent Clinical Trials for LUCENTIS
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Faculty Hospital Kralovske Vinohrady | Phase 4 |
| Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Phase 2 |
| Lupin Ltd. | Phase 3 |
Recent Litigation for LUCENTIS
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Novartis Pharma AG v. Regeneron Pharmaceuticals, Inc. | 2020-06-19 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| Regeneron Pharmaceuticals, Inc. | 2020-07-16 |
Pharmacology for LUCENTIS
Patent Text Search: US Patents for LUCENTIS
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | LUCENTIS | ranibizumab | INJECTABLE; INJECTION | 125156 | 001 | 2006-06-30 | Start Trial | Avalanche Australia Pty Ltd. (Southbank, AU) | 2032-05-15 | RX | search | |
| Genentech | LUCENTIS | ranibizumab | INJECTABLE; INJECTION | 125156 | 001 | 2006-06-30 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Genentech | LUCENTIS | ranibizumab | INJECTABLE; INJECTION | 125156 | 001 | 2006-06-30 | Start Trial | Pharmacyclics LLC (Sunnyvale, CA) | 2033-08-12 | RX | search | |
| Genentech | LUCENTIS | ranibizumab | INJECTABLE; INJECTION | 125156 | 001 | 2006-06-30 | Start Trial | Bayer Pharma Aktiengesellschaft (Berlin, DE) | 2034-11-25 | RX | search | |
| Genentech | LUCENTIS | ranibizumab | INJECTABLE; INJECTION | 125156 | 001 | 2006-06-30 | Start Trial | Agency for Science, Technology and Research (Singapore, SG) | 2034-05-09 | RX | search | |
| Genentech | LUCENTIS | ranibizumab | INJECTABLE; INJECTION | 125156 | 001 | 2006-06-30 | Start Trial | Advenchen Pharmaceuticals, LLC (Moorpark, CA) | 2035-05-04 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for LUCENTIS
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Chile | 2013000152 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2012028733 | Start Trial |
| European Patent Office | 2358760 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2006086750 | Start Trial |
| Japan | 2008150358 | Start Trial |
| Canada | 2602525 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
